Latanoprost

Overview

Latanoprost is a prostaglandin F2α analog used as an ophthalmic solution to lower intraocular pressure in glaucoma patients. It works by increasing the outflow of aqueous fluid from the eyes.

API suppliers (19)

Suppliers of Latanoprost backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• CHIROGATE INTERNATIONAL INCTaiwan1 active DMF
• TAPI NL BV1 active DMF
• FDC LimitedIndia1 active DMF
• CHIROGATE INTERNATIONAL INCTaiwan1 active DMF
• CHIROGATE INTERNATIONAL INCTaiwan1 active DMF
• CAYMAN PHARMA SRO1 active DMF
• DELTA BIOTECH SA1 active DMF
• YS LIFE SCIENCE CO LTD1 active DMF
• EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan1 active DMF
• CHIROGATE INTERNATIONAL INCTaiwan1 active DMF
• YS LIFE SCIENCE CO LTD1 active DMF
• EVERLIGHT CHEMICAL INDUSTRIAL CORPTaiwan1 active DMF
• TAPI NL BV1 active DMF
• C-SQUARED PHARMA LTD1 active DMF
• FDC LimitedIndia1 active DMF
• MYLAN LABORATORIES LTD
• RESOLUTION CHEMICALS LTD
• Lupin LimitedIndia
• PATHEON API MANUFACTURING INC

Patent & exclusivity (US)

Per the FDA Orange Book (10 approved US products), the latest listed US patent on Latanoprost expires 7 Jul 2031. Generic API sourcing typically opens up once these lapse.

Therapeutic areas